The bladder that won't wait
Urgency, frequency, and the night-time trips that wreck sleep — a syndrome that quietly destroys quality of life and is badly handled almost everywhere outside urology. The treatment is a clean ladder, and the first rung is a bladder diary, not a pill.
The one-liner
OAB is a clinical diagnosis treated up a ladder: behavioral therapy → a β3-agonist or antimuscarinic → third-line BTX/sacral neuromodulation/PTNS. Start with a 3-day voiding diary, prefer the β3-agonist when the post-void residual is high, and mind anticholinergic burden in the elderly. In neurogenic bladder, the real job is protecting the kidneys.
Overactive bladder is a storage problem: urinary urgency, usually with frequency and nighttime voiding, with or without urge incontinence. It is enormously common, it quietly dismantles quality of life and sleep, and it is poorly understood by most clinicians who aren’t urologists — which means it is often either ignored or treated with the wrong drug first. The good news is that the management is one of the cleanest ladders in the specialty.
First, the diary — and ruling out the mimics
Before any prescription, two things. A 3-day voiding diaryturns “I go all the time” into volumes and frequencies you can actually treat — and it catches the patient whose real problem is polyuria (making too much urine, > 3 L/day) or nocturnal polyuria (making too much of it at night), which is a different disease with a different fix.
And OAB is a diagnosis of exclusion: a urinalysis to exclude infection, and a thought for the secondary causes — bladder outlet obstruction, a bladder stone, or a tumor — especially if there is hematuria. Treat those on their own terms.
What everyone gets wrong
Reaching for an antimuscarinic in the older man with a big post-void residual. Antimuscarinics relax the detrusor — which can tip a marginally emptying bladder into retention — and they carry real anticholinergic burden (dry mouth, constipation, cognitive effects) that matters most in exactly the elderly patients who get OAB. When the residual is elevated or the patient is frail, prefer the β3-agonist.
The ladder
- Behavioral therapy(first-line, 4–6 weeks) — fluid and caffeine moderation, timed and double voiding, bladder retraining, pelvic floor work, weight loss. Genuinely effective and free of side effects.
- Drug therapy — a β3-agonist (mirabegron, vibegron) or an antimuscarinic (solifenacin, tolterodine, and others). The β3 has no anticholinergic load but can nudge blood pressure. The two classes can be combined when one alone falls short.
- Third-line therapies for refractory symptoms:
- Intradetrusor botulinum toxin — 100 units for idiopathic OAB, injected cystoscopically. Counsel about the 5–10% risk of needing self-catheterizationand re-treatment every 6–9 months.
- Sacral neuromodulation — a two-stage implanted S3 lead, ~70% durable success.
- Posterior tibial nerve stimulation — weekly office sessions, then maintenance.
Behavioral therapy is the rung everyone wants to skip and shouldn’t. A diary and a few habit changes outperform a lot of prescriptions, with none of the dry mouth.
The neurogenic bladder is a different game
When the cause is neurologic — spinal cord injury, multiple sclerosis, spina bifida — symptom relief is not the main goal. Protecting the upper tracts is. A hostile bladder — small, poorly compliant, high detrusor pressure, often with detrusor-sphincter dyssynergia — silently transmits pressure back to the kidneys and is, classically, the most missed diagnosis in urology.
The threshold to remember is McGuire’s rule: a detrusor leak-point pressure above 40 cm H₂O puts the kidneys at risk. Urodynamics finds it; management is clean intermittent catheterization plus bladder relaxation (antimuscarinic, β3, or 200 units of botulinum toxin), and augmentation cystoplasty for the refractory bladder — but only in a patient who will commit to catheterizing for life.
If you remember one thing
Diary first, then climb the ladder one rung at a time. In idiopathic OAB the worst outcome is a bothered patient; in neurogenic bladder the worst outcome is a dead kidney — so when there’s a neurologic cause, find the hostile bladder before it finds the kidney.